Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.883 EUR | -1.19% | +2.66% | -58.25% |
May. 30 | Evotec Partners With French Institutions, Company to Research Obesity | MT |
May. 30 | Evotec Joins Collaboration to Identify New Therapies for Obesity, Metabolic Diseases | MT |
Sales 2024 * | 881M 960M | Sales 2025 * | 1.04B 1.13B | Capitalization | 1.59B 1.74B |
---|---|---|---|---|---|
Net income 2024 * | -27M -29.4M | Net income 2025 * | 32M 34.85M | EV / Sales 2024 * | 2.11 x |
Net Debt 2024 * | 269M 293M | Net Debt 2025 * | 235M 256M | EV / Sales 2025 * | 1.76 x |
P/E ratio 2024 * |
-60.6
x | P/E ratio 2025 * |
33.5
x | Employees | 5,055 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.64% |
Latest transcript on Evotec SE
1 day | -0.47% | ||
1 week | +7.02% | ||
Current month | +3.87% | ||
1 month | -6.40% | ||
3 months | -31.30% | ||
6 months | -52.22% | ||
Current year | -57.75% |
Managers | Title | Age | Since |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19-06-18 |
Laetitia Rouxel
DFI | Director of Finance/CFO | 51 | 23-02-06 |
Craig Johnstone
COO | Chief Operating Officer | 54 | 12-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19-06-18 |
Roland Sackers
BRD | Director/Board Member | 56 | 19-06-18 |
Chairman | 63 | 14-06-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.68% | 17 M€ | -.--% | - | |
2.59% | 202 M€ | -.--% | ||
0.21% | 79 M€ | -.--% | ||
0.15% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 8.885 | -1.17% | 449 236 |
24-06-06 | 8.99 | -0.61% | 591,622 |
24-06-05 | 9.045 | +1.34% | 666,458 |
24-06-04 | 8.925 | -1.22% | 1,037,721 |
24-06-03 | 9.035 | +4.39% | 1,427,281 |
Delayed Quote Xetra, June 06, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.75% | 1.73B | |
+55.55% | 59.28B | |
+43.17% | 40.94B | |
-4.71% | 40.17B | |
-5.56% | 28.69B | |
+13.76% | 26.63B | |
-22.00% | 18.89B | |
+31.50% | 12.46B | |
+2.16% | 12.42B | |
+25.70% | 12.26B |
- Stock Market
- Equities
- EVT Stock